Grifols SA Files Form 6-K
Ticker: GIKLY · Form: 6-K · Filed: Jul 5, 2024 · CIK: 1438569
| Field | Detail |
|---|---|
| Company | Grifols SA (GIKLY) |
| Form Type | 6-K |
| Filed Date | Jul 5, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: disclosure, foreign-private-issuer
TL;DR
Grifols SA filed a 6-K on July 5th, likely with new info for investors.
AI Summary
Grifols, S.A. filed a Form 6-K on July 5, 2024, to report other relevant information dated July 4, 2024. The filing is a report of a foreign private issuer and does not contain specific financial figures or operational details in the provided text.
Why It Matters
This filing indicates Grifols, S.A. is providing an update or disclosure as required for foreign private issuers, which could contain material information for investors.
Risk Assessment
Risk Level: low — The filing is a standard disclosure document (6-K) and the provided text does not contain any specific negative or positive financial or operational news.
Key Players & Entities
- Grifols, S.A. (company) — Registrant
- 0001104659-24-078055 (filing_id) — Accession Number
- July 5, 2024 (date) — Filing Date
- July 4, 2024 (date) — Report Date
FAQ
What type of filing is this?
This is a Form 6-K, a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
Who is the filer?
The filer is Grifols, S.A.
When was this filing submitted?
The filing was submitted on July 5, 2024.
What period does this report cover?
The report is for the month of July 2024, with a conforming period of report of July 4, 2024.
What is the company's primary business classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Filing Stats: 376 words · 2 min read · ~1 pages · Grade level 10 · Accepted 2024-07-05 14:09:30
Filing Documents
- tm2418944d1_6k.htm (6-K) — 16KB
- tm2418944d1_6kimg001.jpg (GRAPHIC) — 19KB
- 0001104659-24-078055.txt ( ) — 43KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereto duly authorized. Grifols, S.A. By: /s/ David I. Bell Name: David I. Bell Title: Authorized Signatory Date: July 4, 2024